Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Opus Genetics ( (IRD) ).
On April 2, 2026, Opus Genetics, Inc. entered into a senior secured note purchase agreement allowing for the issuance of up to $155 million in senior secured notes, with $105 million committed by purchasers and $50 million remaining uncommitted. The notes are issued in tranches tied to customary funding conditions and, in some cases, specified milestones, providing the company with staged access to growth capital.
The initial $35 million tranche was funded on April 21, 2026, with notes issued at par that mature on April 21, 2033 and bear floating interest based on Term SOFR plus a margin, payable quarterly. These initial notes are secured by substantially all of the company’s and certain subsidiaries’ assets, are guaranteed by certain subsidiaries, and include customary default provisions, underscoring a significant leveraging of the balance sheet to finance operations and strategic objectives.
The most recent analyst rating on (IRD) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Opus Genetics stock, see the IRD Stock Forecast page.
Spark’s Take on IRD Stock
According to Spark, TipRanks’ AI Analyst, IRD is a Neutral.
The score is held back primarily by deteriorating financial performance (declining revenue, large losses, and heavy cash burn), partially offset by strong technical momentum and supportive corporate financing events that may extend runway. Valuation remains constrained by negative earnings and no indicated dividend support.
To see Spark’s full report on IRD stock, click here.
More about Opus Genetics
Opus Genetics, Inc. is a Delaware-based company operating in the life sciences sector. It focuses on developing genetic therapies and related technologies, with a capital structure that includes secured debt financing to support its research, development, and operational growth initiatives.
Average Trading Volume: 975,649
Technical Sentiment Signal: Hold
Current Market Cap: $372M
See more data about IRD stock on TipRanks’ Stock Analysis page.